Accordingly, the areas of unmet need for new treatments are reflected in the lesions that underly the hyperglycaemia, notably impaired function and number of pancreatic beta cells, insulin resistance and glucose toxicity, which are frequently aggravated by excess adiposity, abnormalities of glucagon secretion, an altered incretin response and disturbances in lipid metabolism [6]
It decreases lipogenesis (fat creation) in the liver
(Read more about this disease, which is especially common among Hispanic men.) And evidence is building that GLP-1 medications may help with cancer prevention and addiction
Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: From bench to patient care
What does the post credit for the price gap between compounded and branded GLP-1 medications
If you are also considering tirzepatide, the same principles apply, and you can read about drinking on tirzepatide as well